Abstract
Microinjection of peptide YY (PYY, 7–46 pmol) into the dorsal vagal complex (DVC) stimulated gastric acid secretion in urethane-anaesthetized rats. Using a variety of neuropeptide Y (NPY) and PYY derivatives, we characterized the pharmacological profile of the receptor mediating the acid secretory response to PYY.
[Pro34]rat(r)/porcine(p)PYY and [Pro34]human(h)PYY (23–117 pmol), microinjected unilaterally into the DVC resulted in a similar maximal increase in net acid secretion reaching 68±11 and 89±31 μmol 90 min−1 respectively.
Rat/hNPY and pNPY (47 pmol) microinjected into the DVC induced a similar net gastric acid secretion (27±8 and 23±8 μmol 90 min−1 respectively) and a higher dose (116 pmol) tended to reduce the response.
Pancreatic polypeptide (PP, 4–46 pmol), [Leu31,Pro34]r/hNPY (47 and 117 pmol) and the Y2 selective agonists, hPYY3-36, pNPY5-36 and pNPY13-36 (25–168 pmol) microinjected into the DVC failed to influence basal gastric acid secretion.
The rank order of potency of PYY⩾[Pro34]r/pPYY=[Pro34]hPYY>r/hNPY=pNPY to stimulate gastric acid secretion upon injection into the DVC and the ineffectiveness of PP, [Leu31,Pro34]NPY and C-terminal NPY/PYY fragments suggest that a PYY-preferring receptor subtype may be involved in mediating the stimulating effect.
Keywords: Neuropeptide Y, PYY3-36, [Pro34]PYY, pancreatic polypeptide, Y1 receptor agonists, Y2 receptor agonists
Full Text
The Full Text of this article is available as a PDF (327.9 KB).